We observed that colorectal cancer patients had mutated KRAS circulating in plasma as well as elevated levels of wild-type KRAS in comparison to healthy controls (p = 0.0066 and p = 0.0002, respectively). The gene discussed is KRAS; the disease is colorectal cancer.